Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer

Title
Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer
Authors
Keywords
-
Journal
CANCER
Volume 116, Issue 5, Pages 1344-1349
Publisher
Wiley
Online
2010-01-16
DOI
10.1002/cncr.24753

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation